Taipei Exchange - Delayed Quote TWD
Syngen Biotech Co.,Ltd. (8279.TWO)
141.50
+6.00
+(4.43%)
At close: 1:09:27 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,031,941
2,013,592
1,837,185
1,930,594
1,471,266
Cost of Revenue
1,299,026
1,289,656
1,193,267
1,242,442
942,926
Gross Profit
732,915
723,936
643,918
688,152
528,340
Operating Expense
425,570
413,717
349,638
307,956
246,536
Operating Income
307,345
310,219
294,280
380,196
281,804
Net Non Operating Interest Income Expense
-6,394
-7,229
-7,434
-4,462
-2,889
Pretax Income
304,468
299,611
333,802
396,415
295,493
Tax Provision
62,871
59,404
58,975
75,179
57,723
Net Income Common Stockholders
241,597
240,207
274,827
321,236
237,770
Diluted NI Available to Com Stockholders
241,597
240,207
274,827
321,236
237,770
Basic EPS
8.92
8.86
10.14
11.85
8.77
Diluted EPS
8.90
8.85
10.13
11.84
8.76
Basic Average Shares
27,074.50
27,101
27,101
27,101
27,101
Diluted Average Shares
27,131.56
27,128
27,128
27,131
27,132
Total Expenses
1,724,596
1,703,373
1,542,905
1,550,398
1,189,462
Net Income from Continuing & Discontinued Operation
241,597
240,207
274,827
321,236
237,770
Normalized Income
242,519.05
245,753.37
267,762.89
335,675.68
238,032.32
Interest Income
2,046
2,047
1,426
609
319
Interest Expense
8,440
9,276
8,860
5,071
3,208
Net Interest Income
-6,394
-7,229
-7,434
-4,462
-2,889
EBIT
312,908
308,887
342,662
401,486
298,701
EBITDA
431,888
423,572
442,136
487,986
380,098
Reconciled Cost of Revenue
1,299,026
1,289,656
1,193,267
1,242,442
942,926
Reconciled Depreciation
118,980
114,685
99,474
86,500
81,397
Net Income from Continuing Operation Net Minority Interest
241,597
240,207
274,827
321,236
237,770
Total Unusual Items Excluding Goodwill
-1,162
-6,918
8,580
-17,819
-326
Total Unusual Items
-1,162
-6,918
8,580
-17,819
-326
Normalized EBITDA
433,050
430,490
433,556
505,805
380,424
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-239.95
-1,371.63
1,515.89
-3,379.32
-63.68
12/31/2021 - 11/14/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
88.80
-1.55%
6662.TWO BioLASCO Taiwan Co., Ltd.
32.50
-2.99%
3118.TWO Level Biotechnology Inc.
33.35
0.00%
4728.TWO Sunmax Biotechnology Co., Ltd.
424.50
-5.56%
4192.TWO SynCore Biotechnology Co.,Ltd
29.20
-2.67%
6712.TWO Ever Supreme Bio Technology Co., Ltd
163.50
-0.30%
6885.TW BRIM Biotechnology, Inc.
21.95
-2.23%
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
102.00
+2.00%
6733.TWO BioGend Therapeutics Co., Ltd.
27.95
-0.36%
3205.TWO Sagittarius Life Science Corp
24.15
+0.62%